Updated:
Norgine Ventures
Norgine Ventures was established in 2012 as a subsidiary of Norgine, a private European healthcare company founded over 100 years ago. Norgine Ventures...
Norgine Ventures
Norgine Ventures was established in 2012 as a subsidiary of Norgine, a private European healthcare company founded over 100 years ago. Norgine Ventures provides debt financing to healthcare and life sciences companies in Europe and the US. The firm has invested in various businesses, including specialty pharma, diagnostic, and medical device companies at different stages of their development.
General information
Firm type
Venture Capital
Year founded
2012
Location
Region
Europe
Country
United Kingdom
City
Uxbridge
Corporate office
Uxbridge, United Kingdom
Sector focus
Frequently asked questions
How does Norgine Ventures finance its investments?
The firm invests directly from Norgine's corporate balance sheet, allowing it to provide growth-stage venture debt alongside minority equity stakes. This structure means it does not raise external funds or operate under fixed fund-life constraints, giving portfolio companies a capital partner that can hold positions indefinitely.
Does Norgine Ventures lead investment rounds or co-invest alongside other firms?
Norgine Ventures commonly provides venture debt as a complement to equity rounds led by traditional venture capital firms. This hybrid approach gives companies non-dilutive growth capital while Norgine takes minority equity exposure, allowing founders and existing investors to retain control.
What is the typical investment size and geographic focus?
The firm writes checks generally ranging from €5 million to €20 million, concentrating on companies headquartered in Western Europe. It has also evaluated opportunities in Israel and the Nordic region, reflecting the broader European footprint of its parent company's commercial operations.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: